Home

BRIAN DANIELS

CIK 1428698 · SVP Global Dev & Med Affairs · last filed 2026-09-08

BRIAN DANIELS is a SVP Global Dev & Med Affairs who has filed 45 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for ARTV, was dated Sep 8, 2026. Across all open-market trades the lifetime net is −$5.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.0M across reported positions. 41 SEC filings were submitted jointly with MYERS SQUIBB CO BRISTOL.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.01M

Companies

3

Total Filings

45

Lifetime Open-Market Net

-$5.84M

Filer Profile

Reported Address
C/O 5AM VENTURE MANAGEMENT, LLC
4 EMBARCADERO CENTER, SUITE 3110
SAN FRANCISCO, CA 94111
Related Filers
MYERS SQUIBB CO BRISTOL — 41 joint filings, latest 2014-07-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARTV Director — $10.22 — $0 2 2026-09-08
CABA Director — $2.73 — $0 3 2021-06-28
BMY SVP Global Dev & Med Affairs 94,374 $63.64 $6.01M -$5.84M 40 2014-07-02

Recent Filings

45 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-08 ARTV Grant (A) — $0 EDGAR
2025-06-26 ARTV Grant (A) — $0 EDGAR
2021-06-28 CABA Grant (A) — $0 EDGAR
2021-06-03 CABA Grant (A) — $0 EDGAR
2020-02-13 CABA Grant (A) — $0 EDGAR
2014-07-02 BMY Mixed +2,568 -$101.2K EDGAR
2014-03-12 BMY Mixed +2,020 -$92.9K EDGAR
2014-03-10 BMY Mixed +2,778 -$126.5K EDGAR
2014-03-05 BMY Mixed +33,459 -$1.30M EDGAR
2014-02-06 BMY Mixed −9,690 -$864.4K EDGAR
Showing 1–10 of 45
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.